Showing results (81-90 of 164) with videos related to

Sort By:
Pageof 17
Journal of Gastroenterology|August 30, 2017
Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts hepatocellular carcinoma incidence and recurrence in nucleos(t)ide analogue therapy for chronic hepatitis BKazunori Kawaguchi, Masao Honda, Hajime Ohta, et al.
Translational Oncology|May 16, 2020
Safety and Long-Term Outcome of Intratumoral Injection of OK432-Stimulated Dendritic Cells for Hepatocellular Carcinomas After Radiofrequency AblationMasaaki Kitahara, Eishiro Mizukoshi, Takeshi Terashima, et al.
Hepatology (Baltimore, Md.)|August 14, 2018
Characteristics of Immune Response to Tumor-Associated Antigens and Immune Cell Profile in Patients With Hepatocellular CarcinomaYuki Inada, Eishiro Mizukoshi, Takuya Seike, et al.
Cancer Letters|May 3, 2011
Frequency of CD45RO+ subset in CD4+CD25(high) regulatory T cells associated with progression of hepatocellular carcinomaYoshiko Takata, Yasunari Nakamoto, Akiko Nakada, et al.
Metabolism: Clinical and Experimental|April 24, 2012
Beneficial effect of branched-chain amino acid supplementation on glycemic control in chronic hepatitis C patients with insulin resistance: implications for type 2 diabetesYumie Takeshita, Toshinari Takamura, Yuki Kita, et al.
Scientific Reports|February 9, 2019
Notch signaling facilitates hepatitis B virus covalently closed circular DNA transcription via cAMP response element-binding protein with E3 ubiquitin ligase-modulationZijing Wang, Kazunori Kawaguchi, Masao Honda, et al.
Journal of Gastroenterology|February 2, 2019
Serum aldo-keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitisMasataka Kanno, Kazunori Kawaguchi, Masao Honda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 11, 2023
Successful second-line treatment with cabozantinib for hepatocellular carcinoma harboring cytoplasmic mesenchymal-epithelial transition factor amplificationMakoto Yamamoto, Takeshi Terashima, Tatsuya Yamashita, et al.
Gastroenterology|May 4, 2010
Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis CMasao Honda, Akito Sakai, Tatsuya Yamashita, et al.
Nature Communications|June 6, 2022
Peptide vaccine-treated, long-term surviving cancer patients harbor self-renewing tumor-specific CD8<sup>+</sup> T cellsEishiro Mizukoshi, Hidetoshi Nakagawa, Toshikatsu Tamai, et al.
Pageof 17